Which are the Top 20 Companies in the Suppositories Market?
- Pfizer Inc.
- GlaxoSmithKline plc
- Ferring Pharmaceuticals
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Mylan N.V.
- Johnson & Johnson
- Sanofi S.A.
- Bristol-Myers Squibb
- Abbott Laboratories
- Boehringer Ingelheim
- Cipla Limited
- Sun Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals
- Pharmathen S.A.
- Recordati S.p.A.
- Wockhardt Limited
- Meda AB
- Lupin Limited
- Astellas Pharma Inc.
Market Growth
The global suppositories market size is calculated at US$ 1.6 billion in 2024, grew to US$ 1.68 billion in 2025, and is projected to reach around US$ 2.55 billion by 2034. The market is expanding at a CAGR of 4.67% between 2025 and 2034.
Suppositories Market Trends
Expanding pipeline: Different types of suppositories are being developed due to growing women’s health issues, chronic diseases, aging population, etc. This, in turn, is increasing their development as well as distribution. Moreover, the growing acquisitions and investments are supporting these advancements.
For instance,
- In June 2025, the acquisition of a suppository form of Mesalazine by Shanghai Ethypharm Pharmaceuticals was announced by Ethypharm, which is France-headquartered. The advanced of targeted release is provided by this Mesalazine suppository treatment.
- In March 2025, to expand the Texas manufacturing facility that is Rosenberg, an investment of over $6 million as part of the Phase I CDMO growth strategy was announced by LGM Pharma. The capacity for suppository, suspension, liquid, and semi-solid drug products will be increased in this expansion.
Suppositories Market Value Chain Analysis
R&D
The R&D of suppositories focuses on the development of controlled-release, targeted, personalized, herbal, and probiotic formulations.
Key players: AG, Novartis AG, Sanofi
Formulation and Final Dosage Preparation
3 different methods, such as rolling (hand-shaping), cold compression, and molding (fusion), are the methods used for formulating suppositories.
Packaging and Serialization
Blister, strip, and bottle are the commonly used packaging types, where blister packs composed of Alu/PE or PVC/PE are becoming the preferred option as they offer ease of handling, application, and dispensing.
Key players: CordenPharma, Recipharm AB, NextPharma Technologies
Patient Support and Services
The patients are being provided with instructions or guidelines for the use of suppositories, which is increasing their safety and compliance with the treatment.
What is the Latest Announcement by the Industry Leader?
In September 2024, after revealing the URO Boric Acid Suppositor, the OB/GYN and medical advisor at O Positiv Health, Dr. Jessica Shepherd, commented that to provide exceptional comfort and maximum efficacy, they have used soothing aloe, boric acid, and lactic acid for formulating the URO boric acid vaginal suppository. Thus, with this formulation, the urgent vaginal health needs are addressed by offering a gentle touch.
What are the Recent Developments in the Suppositories Market?
- In August 2025, to clinically validate boric acid suppositories for the treatment of yeast infections, the first randomized, placebo-controlled, double-blinded Phase 3 clinical trial was initiated by pH-D Feminine Health. They are also focusing on the submission of their New Drug Application (NDA).
- In June 2025, a line of CBD-infused rectal and vaginal suppositories was launched by CBD Life Sciences Inc. Different types of conditions, such as endometriosis, gastrointestinal discomfort, menstrual cramps, and pelvic floor dysfunction, will be provided with targeted relief with this innovative product.
Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com
